Lentiviral Vector Production System Market Size(US$)

CAGR 2026-2032
11.3%
Market Size,2032
USD 2,623
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Lentiviral Vector Production System market size was US$ 1252 million in 2025 and is forecast to reach a readjusted size of US$ 2623 million by 2032 with a CAGR of 11.3% during the forecast period 2026-2032.
Lentiviral Vector Production System refers to an integrated set of cell culture, transfection or producer cell line, vector plasmid, packaging, envelope, harvest, purification and quality control processes used to generate lentiviral vector particles for gene delivery, cell therapy, gene therapy research and biomanufacturing applications. The system typically relies on producer cells, commonly HEK293 or HEK293T derived cells, that supply the necessary viral packaging functions while carrying the target genetic payload in a transfer vector, enabling production of replication deficient lentiviral particles that can efficiently deliver genetic material into target cells.
The Lentiviral Vector Production System market is shifting from research-scale vector preparation toward clinical-grade and commercial manufacturing. Demand is mainly driven by cell therapy, gene therapy and functional genomics applications. As gene-modified cell therapy programs continue to advance, customers increasingly require high-titer, high-purity, low-residual, scalable and GMP-compliant production systems. This is driving the market from standalone transfection or packaging reagents toward end-to-end process platforms covering cell culture, plasmid supply, viral packaging, harvest and clarification, purification and concentration, and quality control. Future competition will focus on production efficiency, batch-to-batch consistency, closed and automated processing, regulatory compliance, and process transferability from research-grade to clinical-grade manufacturing.
The global Lentiviral Vector Production System market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size and Growth by Type: 2021 vs 2025 vs 2032
1.2.2 Production Workflow Products
1.2.3 GMP Manufacturing Services
1.2.4 Research-grade Packaging Services
1.3 Market by Application
1.3.1 Global Market Share by Application: 2021 vs 2025 vs 2032
1.3.2 Cell Therapy
1.3.3 Gene Therapy
1.3.4 Basic Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lentiviral Vector Production System Market Perspective (2021-2032)
2.2 Global Market Size by Region: 2021 vs 2025 vs 2032
2.3 Global Lentiviral Vector Production System Market Share by Revenue, by Region (2021-2026)
2.4 Global Lentiviral Vector Production System Revenue Forecast by Region (2027-2032)
2.5 Major Regions and Emerging Markets Analysis
2.5.1 North America Lentiviral Vector Production System Market Size and Prospective (2021-2032)
2.5.2 Europe Lentiviral Vector Production System Market Size and Prospective (2021-2032)
2.5.3 China Lentiviral Vector Production System Market Size and Prospective (2021-2032)
2.5.4 Japan Lentiviral Vector Production System Market Size and Prospective (2021-2032)
3 Breakdown Data by Type
3.1 Global Lentiviral Vector Production System Historical Market Size by Type (2021-2026)
3.2 Global Lentiviral Vector Production System Forecasted Market Size by Type (2027-2032)
3.3 Representative Players for Different Types of Lentiviral Vector Production System
4 Breakdown Data by Application
4.1 Global Lentiviral Vector Production System Historical Market Size by Application (2021-2026)
4.2 Global Lentiviral Vector Production System Forecasted Market Size by Application (2027-2032)
4.3 New Sources of Growth in Lentiviral Vector Production System Applications
5 Competitive Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Lentiviral Vector Production System Players by Revenue (2021-2026)
5.1.2 Global Lentiviral Vector Production System Market Share by Revenue, by Players (2021-2026)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Lentiviral Vector Production System Revenue
5.4 Global Lentiviral Vector Production System Market Concentration Analysis
5.4.1 Global Lentiviral Vector Production System Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Lentiviral Vector Production System Revenue in 2025
5.5 Global Key Players of Lentiviral Vector Production System Head Offices and Areas Served
5.6 Global Key Players of Lentiviral Vector Production System, Product and Application
5.7 Global Key Players of Lentiviral Vector Production System, Date of Entry into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Lentiviral Vector Production System Revenue by Company (2021-2026)
6.1.2 North America Market Size by Type
6.1.2.1 North America Lentiviral Vector Production System Market Size by Type (2021-2026)
6.1.2.2 North America Lentiviral Vector Production System Market Share by Type (2021-2026)
6.1.3 North America Market Size by Application
6.1.3.1 North America Lentiviral Vector Production System Market Size by Application (2021-2026)
6.1.3.2 North America Lentiviral Vector Production System Market Share by Application (2021-2026)
6.1.4 North America Lentiviral Vector Production System Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Lentiviral Vector Production System Revenue by Company (2021-2026)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Lentiviral Vector Production System Market Size by Type (2021-2026)
6.2.2.2 Europe Lentiviral Vector Production System Market Share by Type (2021-2026)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Lentiviral Vector Production System Market Size by Application (2021-2026)
6.2.3.2 Europe Lentiviral Vector Production System Market Share by Application (2021-2026)
6.2.4 Europe Lentiviral Vector Production System Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Lentiviral Vector Production System Revenue by Company (2021-2026)
6.3.2 China Market Size by Type
6.3.2.1 China Lentiviral Vector Production System Market Size by Type (2021-2026)
6.3.2.2 China Lentiviral Vector Production System Market Share by Type (2021-2026)
6.3.3 China Market Size by Application
6.3.3.1 China Lentiviral Vector Production System Market Size by Application (2021-2026)
6.3.3.2 China Lentiviral Vector Production System Market Share by Application (2021-2026)
6.3.4 China Lentiviral Vector Production System Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Lentiviral Vector Production System Revenue by Company (2021-2026)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Lentiviral Vector Production System Market Size by Type (2021-2026)
6.4.2.2 Japan Lentiviral Vector Production System Market Share by Type (2021-2026)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Lentiviral Vector Production System Market Size by Application (2021-2026)
6.4.3.2 Japan Lentiviral Vector Production System Market Share by Application (2021-2026)
6.4.4 Japan Lentiviral Vector Production System Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Key Player Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Details
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Lentiviral Vector Production System Introduction
7.1.4 Thermo Fisher Scientific Revenue in Lentiviral Vector Production System Business (2021-2026)
7.1.5 Thermo Fisher Scientific Recent Development
7.2 Lonza
7.2.1 Lonza Company Details
7.2.2 Lonza Business Overview
7.2.3 Lonza Lentiviral Vector Production System Introduction
7.2.4 Lonza Revenue in Lentiviral Vector Production System Business (2021-2026)
7.2.5 Lonza Recent Development
7.3 Charles River
7.3.1 Charles River Company Details
7.3.2 Charles River Business Overview
7.3.3 Charles River Lentiviral Vector Production System Introduction
7.3.4 Charles River Revenue in Lentiviral Vector Production System Business (2021-2026)
7.3.5 Charles River Recent Development
7.4 Merck
7.4.1 Merck Company Details
7.4.2 Merck Business Overview
7.4.3 Merck Lentiviral Vector Production System Introduction
7.4.4 Merck Revenue in Lentiviral Vector Production System Business (2021-2026)
7.4.5 Merck Recent Development
7.5 Cytiva
7.5.1 Cytiva Company Details
7.5.2 Cytiva Business Overview
7.5.3 Cytiva Lentiviral Vector Production System Introduction
7.5.4 Cytiva Revenue in Lentiviral Vector Production System Business (2021-2026)
7.5.5 Cytiva Recent Development
7.6 OXB
7.6.1 OXB Company Details
7.6.2 OXB Business Overview
7.6.3 OXB Lentiviral Vector Production System Introduction
7.6.4 OXB Revenue in Lentiviral Vector Production System Business (2021-2026)
7.6.5 OXB Recent Development
7.7 AGC Biologics
7.7.1 AGC Biologics Company Details
7.7.2 AGC Biologics Business Overview
7.7.3 AGC Biologics Lentiviral Vector Production System Introduction
7.7.4 AGC Biologics Revenue in Lentiviral Vector Production System Business (2021-2026)
7.7.5 AGC Biologics Recent Development
7.8 OriGene
7.8.1 OriGene Company Details
7.8.2 OriGene Business Overview
7.8.3 OriGene Lentiviral Vector Production System Introduction
7.8.4 OriGene Revenue in Lentiviral Vector Production System Business (2021-2026)
7.8.5 OriGene Recent Development
7.9 Sartorius
7.9.1 Sartorius Company Details
7.9.2 Sartorius Business Overview
7.9.3 Sartorius Lentiviral Vector Production System Introduction
7.9.4 Sartorius Revenue in Lentiviral Vector Production System Business (2021-2026)
7.9.5 Sartorius Recent Development
7.10 OmniaBio
7.10.1 OmniaBio Company Details
7.10.2 OmniaBio Business Overview
7.10.3 OmniaBio Lentiviral Vector Production System Introduction
7.10.4 OmniaBio Revenue in Lentiviral Vector Production System Business (2021-2026)
7.10.5 OmniaBio Recent Development
7.11 SignaGen Laboratories
7.11.1 SignaGen Laboratories Company Details
7.11.2 SignaGen Laboratories Business Overview
7.11.3 SignaGen Laboratories Lentiviral Vector Production System Introduction
7.11.4 SignaGen Laboratories Revenue in Lentiviral Vector Production System Business (2021-2026)
7.11.5 SignaGen Laboratories Recent Development
7.12 Cellomics Technology
7.12.1 Cellomics Technology Company Details
7.12.2 Cellomics Technology Business Overview
7.12.3 Cellomics Technology Lentiviral Vector Production System Introduction
7.12.4 Cellomics Technology Revenue in Lentiviral Vector Production System Business (2021-2026)
7.12.5 Cellomics Technology Recent Development
7.13 Miltenyi Bioindustry
7.13.1 Miltenyi Bioindustry Company Details
7.13.2 Miltenyi Bioindustry Business Overview
7.13.3 Miltenyi Bioindustry Lentiviral Vector Production System Introduction
7.13.4 Miltenyi Bioindustry Revenue in Lentiviral Vector Production System Business (2021-2026)
7.13.5 Miltenyi Bioindustry Recent Development
7.14 Gene Universal
7.14.1 Gene Universal Company Details
7.14.2 Gene Universal Business Overview
7.14.3 Gene Universal Lentiviral Vector Production System Introduction
7.14.4 Gene Universal Revenue in Lentiviral Vector Production System Business (2021-2026)
7.14.5 Gene Universal Recent Development
7.15 Takara Bio
7.15.1 Takara Bio Company Details
7.15.2 Takara Bio Business Overview
7.15.3 Takara Bio Lentiviral Vector Production System Introduction
7.15.4 Takara Bio Revenue in Lentiviral Vector Production System Business (2021-2026)
7.15.5 Takara Bio Recent Development
7.16 Gentarget
7.16.1 Gentarget Company Details
7.16.2 Gentarget Business Overview
7.16.3 Gentarget Lentiviral Vector Production System Introduction
7.16.4 Gentarget Revenue in Lentiviral Vector Production System Business (2021-2026)
7.16.5 Gentarget Recent Development
7.17 Genezen
7.17.1 Genezen Company Details
7.17.2 Genezen Business Overview
7.17.3 Genezen Lentiviral Vector Production System Introduction
7.17.4 Genezen Revenue in Lentiviral Vector Production System Business (2021-2026)
7.17.5 Genezen Recent Development
7.18 Creative Biogene
7.18.1 Creative Biogene Company Details
7.18.2 Creative Biogene Business Overview
7.18.3 Creative Biogene Lentiviral Vector Production System Introduction
7.18.4 Creative Biogene Revenue in Lentiviral Vector Production System Business (2021-2026)
7.18.5 Creative Biogene Recent Development
7.19 VIVEbiotech
7.19.1 VIVEbiotech Company Details
7.19.2 VIVEbiotech Business Overview
7.19.3 VIVEbiotech Lentiviral Vector Production System Introduction
7.19.4 VIVEbiotech Revenue in Lentiviral Vector Production System Business (2021-2026)
7.19.5 VIVEbiotech Recent Development
7.20 SK pharmteco
7.20.1 SK pharmteco Company Details
7.20.2 SK pharmteco Business Overview
7.20.3 SK pharmteco Lentiviral Vector Production System Introduction
7.20.4 SK pharmteco Revenue in Lentiviral Vector Production System Business (2021-2026)
7.20.5 SK pharmteco Recent Development
7.21 Esco Aster
7.21.1 Esco Aster Company Details
7.21.2 Esco Aster Business Overview
7.21.3 Esco Aster Lentiviral Vector Production System Introduction
7.21.4 Esco Aster Revenue in Lentiviral Vector Production System Business (2021-2026)
7.21.5 Esco Aster Recent Development
7.22 Andelyn Biosciences
7.22.1 Andelyn Biosciences Company Details
7.22.2 Andelyn Biosciences Business Overview
7.22.3 Andelyn Biosciences Lentiviral Vector Production System Introduction
7.22.4 Andelyn Biosciences Revenue in Lentiviral Vector Production System Business (2021-2026)
7.22.5 Andelyn Biosciences Recent Development
7.23 GENEWIZ
7.23.1 GENEWIZ Company Details
7.23.2 GENEWIZ Business Overview
7.23.3 GENEWIZ Lentiviral Vector Production System Introduction
7.23.4 GENEWIZ Revenue in Lentiviral Vector Production System Business (2021-2026)
7.23.5 GENEWIZ Recent Development
7.24 GenScript ProBio
7.24.1 GenScript ProBio Company Details
7.24.2 GenScript ProBio Business Overview
7.24.3 GenScript ProBio Lentiviral Vector Production System Introduction
7.24.4 GenScript ProBio Revenue in Lentiviral Vector Production System Business (2021-2026)
7.24.5 GenScript ProBio Recent Development
7.25 VectorBuilder
7.25.1 VectorBuilder Company Details
7.25.2 VectorBuilder Business Overview
7.25.3 VectorBuilder Lentiviral Vector Production System Introduction
7.25.4 VectorBuilder Revenue in Lentiviral Vector Production System Business (2021-2026)
7.25.5 VectorBuilder Recent Development
7.26 OBiO Tech
7.26.1 OBiO Tech Company Details
7.26.2 OBiO Tech Business Overview
7.26.3 OBiO Tech Lentiviral Vector Production System Introduction
7.26.4 OBiO Tech Revenue in Lentiviral Vector Production System Business (2021-2026)
7.26.5 OBiO Tech Recent Development
7.27 GenePharma
7.27.1 GenePharma Company Details
7.27.2 GenePharma Business Overview
7.27.3 GenePharma Lentiviral Vector Production System Introduction
7.27.4 GenePharma Revenue in Lentiviral Vector Production System Business (2021-2026)
7.27.5 GenePharma Recent Development
7.28 GeneMedi
7.28.1 GeneMedi Company Details
7.28.2 GeneMedi Business Overview
7.28.3 GeneMedi Lentiviral Vector Production System Introduction
7.28.4 GeneMedi Revenue in Lentiviral Vector Production System Business (2021-2026)
7.28.5 GeneMedi Recent Development
7.29 Genevoyager
7.29.1 Genevoyager Company Details
7.29.2 Genevoyager Business Overview
7.29.3 Genevoyager Lentiviral Vector Production System Introduction
7.29.4 Genevoyager Revenue in Lentiviral Vector Production System Business (2021-2026)
7.29.5 Genevoyager Recent Development
7.30 FulenGen
7.30.1 FulenGen Company Details
7.30.2 FulenGen Business Overview
7.30.3 FulenGen Lentiviral Vector Production System Introduction
7.30.4 FulenGen Revenue in Lentiviral Vector Production System Business (2021-2026)
7.30.5 FulenGen Recent Development
8 Lentiviral Vector Production System Market Dynamics
8.1 Lentiviral Vector Production System Industry Trends
8.2 Lentiviral Vector Production System Market Drivers
8.3 Lentiviral Vector Production System Market Challenges
8.4 Lentiviral Vector Production System Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
List of Figures
Related Reports
The global market for Lentiviral Vector Production System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-22
Pages: 86
USD 3950.00
(Single User License)
The global Lentiviral Vector Production System market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-25
Pages: 79
USD 4900.00
(Single User License)
The global market for Lentiviral Vector Production System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-14
Pages: 76
USD 2900.00
(Single User License)
The global market for Lentiviral Vector Production System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 83
USD 3950.00
(Single User License)
The global Lentiviral Vector Production System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 67
USD 4250.00
(Single User License)
The global Lentiviral Vector Production System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 111
USD 4900.00
(Single User License)
The global Lentiviral Vector Production System market was valued at US$ 1252 million in 2025 and is anticipated to reach US$ 2623 million by 2032, at a CAGR of 11.3% from 2026 to 2032.
Published Date: 2026-05-29
Pages: 166
USD 2900.00
(Single User License)
The global market for Lentiviral Vector Production System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-02-11
Pages: 80
USD 3950.00
(Single User License)
The global Lentiviral Vector Production System market is projected to grow from US$ 1252 million in 2025 to US$ 2623 million by 2032, at a CAGR of 11.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-05-29
Pages: 188
USD 4900.00
(Single User License)
The global market for Lentiviral Vector Production System was estimated to be worth US$ 1252 million in 2025 and is projected to reach US$ 2623 million, growing at a CAGR of 11.3% from 2026 to 2032.
Published Date: 2026-05-29
Pages: 171
USD 3950.00
(Single User License)
The global market for Lentiviral Vector Production System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-22
Pages: 86
The global Lentiviral Vector Production System market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-25
Pages: 79
The global market for Lentiviral Vector Production System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-14
Pages: 76
The global market for Lentiviral Vector Production System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 83
The global Lentiviral Vector Production System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 67
The global Lentiviral Vector Production System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 111
The global Lentiviral Vector Production System market was valued at US$ 1252 million in 2025 and is anticipated to reach US$ 2623 million by 2032, at a CAGR of 11.3% from 2026 to 2032.
Published: 2026-05-29
Pages: 166
The global market for Lentiviral Vector Production System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-02-11
Pages: 80
The global Lentiviral Vector Production System market is projected to grow from US$ 1252 million in 2025 to US$ 2623 million by 2032, at a CAGR of 11.3% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-05-29
Pages: 188
The global market for Lentiviral Vector Production System was estimated to be worth US$ 1252 million in 2025 and is projected to reach US$ 2623 million, growing at a CAGR of 11.3% from 2026 to 2032.
Published: 2026-05-29
Pages: 171
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research